The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
about
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The transfer of multigene pane ...... ment of patients and families?
@en
The transfer of multigene pane ...... ment of patients and families?
@nl
type
label
The transfer of multigene pane ...... ment of patients and families?
@en
The transfer of multigene pane ...... ment of patients and families?
@nl
prefLabel
The transfer of multigene pane ...... ment of patients and families?
@en
The transfer of multigene pane ...... ment of patients and families?
@nl
P2093
P2860
P356
P1433
P1476
The transfer of multigene pane ...... ment of patients and families?
@en
P2093
Alexandra Delignette
Amandine Baurand
Anne-Laure Villing
Aurélie Charpin
Axelle Boudrant
Caroline Jacquot
Catherine Loustalot
Charles Coutant
Côme Lepage
France Guy
P2860
P304
P356
10.18632/ONCOTARGET.12699
P407
P577
2017-01-01T00:00:00Z